Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 51 (6), 947-950
- https://doi.org/10.1016/s0015-0282(16)60723-9
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: Assessment by magnetic resonance imagingAmerican Journal of Obstetrics and Gynecology, 1988
- Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormoneFertility and Sterility, 1988
- A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteriFertility and Sterility, 1988
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.BMJ, 1984
- Uterine leiomyomata: etiology, symptomatology, and managementFertility and Sterility, 1981